Abstract
Both factor VIII and the von Willebrand factor (vWF) serve an essential role in the hemostatic proces; factor VIII functions as a cofactor in the intrinsic coagulation pathway (van Dieijen et al. 1981; Mertens et al. 1985) whereas vWF is hemostatically important in the mediation of platelet-vessel wall interactions at sites of vascular injury (Tschopp et al. 1974; Sakariassen et al. 1979). In blood factor VIII and vWF are not present as distinct proteins but rather circulate as non-covalently linked complexes. Several lines of evidence indicate that this phenomenon is of physiological significance. For instance, it now seems clear that vWF functions as a carrier protein and as such has a stabilizing effect on factor VIII. This view stems from the observation that reduced or absent synthesis of vWF (as seen in von Willebrand’s disease) is accompanied with markedly reduced concentrations of plasma factor VIII (Ruggeri and Zimmerman 1987). Similarly, a rise in vWF concentration, as observed in disorders associated with acute-phase reactions, is accompanied with concommitant rises in plasma factor VIII concentrations (Bloom 1979). Taken into account that the half life of factor VIII infused in animals is determined by the presence of endogenous vWF (Brinkhous et al. 1985), these observations clearly illustrate that vWF not only binds to factor VIII but also confers stability to factor VIII in vivo.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bahou W F, Ginsburg D, Sikkink R, Litwiller R, Fass D N (1989) A monoclonal antibody to von Willebrand factor (vWF) inhibits factor VIII binding. J Clin Invest 84: 56
Bloom A L, Giddings J C, Wilks C J (1973) Factor VIII on the vascular intima: possible importance in haemostsis and thrombosis. Nature New Biol 241: 217
Bloom A L (1979) The biosynthesis of factor VIII. Clin Haemat 8: 53
Brinkhous K M, Sanberg H, Garvis J B, Mattsson C, Palm M, Griggs T, Read M S (1985) Purified human factor VIII procoagulant protein: comparative hemostatic response after infusion into hemophilic and von Willebrand disease dogs. Proc Natl Acad Sci USA 82: 8752
Counts R B, Paskell S L, Elgee S K (1978) Disulfide bonds and the quarternary structure of factor VIII/von Willebrand factor. J Clin Invest 62: 792
Ewenstein N M, Warhol M J, Handin R I, Pober J S (1987) Composition of the von Willebrand factor storage organelle ( Weibel-Palade body) isolated from cultured human umbilical vein endothelial cells. J Cell Biol 104: 1423
Fay P J, Kawai Y, Wagner D D, Ginsburg D, Bonthron D, OhlssonWilhelm B M, Chavin S I, Abraham G N, Handin R I, Orkin S H, Montgomery RR, Marder V (1986) Pro-polypeptide of von Willerband factor circulates in blood and is identical to von Willebrand antigen II. Science 232: 995
Folkman J, Haudenschild C C, Zetter B R (1979) Long-term culture of cappillary endothelial cells. Proc Natl Acad Sci USA 76: 5217
Foster P A, Fulcher C A, Marti T, Titani K, Zimmerman T S (1987) A major factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand afctor. J Biol Chem 262: 8443
Foster P A, Fulcher C A, Houghton R.A., Zimmerman T S (1988) An immunogenic region within amino acid residues Va11670-G1u1684 of the factor VIII light chain induces antibodies which inhibit binding of factor VIII to von Willebrand factor. J Biol Chem 263: 5230
Friederich E, Fritz H-J, Huttner W B (1988) Inhibition of Tyrosine sulfation in the trans-Golgi retards the transport of a constitutively secreted protein to the cell surface. J Cell Biol 107: 1655
Hellman L, Smedsröd B, Sandberg H, Petterson U (1989) Secretion of coagulant factor VIII activity and antigen by in vitro cultivated rat liver sinusoidal endothelial cells. Brit J Haematol 73: 348
Higuchi M, Traystman M, Wong C, Olek K, Kazazian H H, Antonarakis S E (1989) Detection of point mutations in hemophilia A using PCR amplification of selected regions of the factor VIII gene. Thromb Haemostas 62: 201 (Abstract)
Hortin G L, Farrier T C, Graham J P, Atkinson J P (1989) Sulfation of tyrosine residues increases activity of the fourth component of complement. Proc Natl Acad Sci USA 86: 1338
Hoyer L W, de los Santos R P, Hoyer J R (1973) Antihemophilic factor antigen. Localization in endothelial cells by immunofluorescence microscopy. J Clin Invest 52: 2737
Huttner W B, Baeuerle P A (1988) Protein sulfation on tyrosine. Modern cell Biology 6: 97
Jaffe E A, Hoyer, L W, Nachman R L (1974) Synthesis of von Willebrand factor by cultured human endothelial cells. Proc Natl Acad Sci USA 71: 1906
Levine J D, Harlan J M, Harker L A (1982) Thrombin-mediated release of factor VIII antigen from umbilical vein endothelial cells in culture. Blood 60: 531
Lewis J H, Bontempo F A, Spero J A, Ragni M V, Starzl T E (1985) Liver transplantation in a hemophiliac. N Engl J Med 312: 1189
Leyte A, Verbeet M Ph, Brodniewicz-Proba T, van Mourik J A, Mertens K, (1989) The interaction between human blood-coagulation factor VIII and von Willebrand factor. Biochem J 257: 697
Leyte A, van Schijndel H B, Verbeet M Ph, Mertens K, van Mourik J A. The tyrosine sulfation site Tyr 1680 of human blood coagulation factor VIII is essential for the interaction of factor VIII with von Willebrand factor. Submitted for publication
Loesberg C, Gonsalves M D, Zandbergen J, Willems Ch, van Aken W G, de Groot Ph G (1983) The effect of calcium on the secretion of factor VIII-related antigen by cultured human endothelial cells. Biochim Biophys Acta 763: 160
Marti T, Rösselet S J, Titani K, Walsh K A (1987) Identification of disulfide-bridged substructures within human von Willebrand factor. Biochemistry 26: 8099
Mazurier C, Dieval J, Jorieux S, Delobel J, Goudemand M (1990) A new von Willebrand factor (vWF) defect in a patient with factor VIII (FVIII) deficiency but with normal levels and multimeric patterns of both plasma and platelet vWF. Characterization of abnormal vWF/FVIII interaction. Blood 75: 20
Mertens K, van Wijngaarden A, Bertina R M (1985) The role of factor VIII in the activation of human blood coagulation factor X by activated factor IX. Thromb Haemostas 54: 654
Nachman R L, Levine R, Jaffe E A (1977) Synthesis of factor VIII antigen by cultured guinea pig megakaryocytes. J Clin Invest 60: 914
Nishino M, Girma J P, Trothschild C, Fressinaud E, Meyer D (1989) New variant of von Willebrand disease with defective binding to factor VIII. Blood 74: 1591
Owen Ch A, Bowie E J W, Fass D N (1979) Generation of factor VIII coagulant activity by isolated, perfused neonatal perfused pig livers and adult rat livers. Brit J Haematol 43: 307
Owen W G, Wagner R H (1972) Antihemophilic factor: Separation of an active fragment following dissociation by salts or detergents. Thromb Diath Haemorrh 27: 502
Pietu G, Ribba A S, Meulie P, Meyer D (1989) Localization within the 106 N-terminal amino acids of von Willerband factor (vWF) of the epitope corresponding to a monoclonal antibody which inhibits vWF binding to factor VIII. Biochem Biophys Res Comm 613: 618
Reinders J H, de Groot Ph G, Dawes J, Hunter N R, van Heugten H A A, Zandbergen J, Gonsalves M D, van Mourik J A (1985) Comparison of secretion and subcellular localization of von Willebrand protein with that of thrombospondin and fibronectin in cultured human vascular endothelial cells. Biochim Biophys Acta 844: 306
Reinders J H, de Groot Ph G, Sixma J J, van Mourik J A (1988) Storage and secretion of von Willebrand factor by endothelial cells (1988) Haemostasis 18: 246
Ruggeri Z M, Zimmerman T S (1987) Von Willebrand factor and von Willebrand disease. Blood 70; 895
Sakariassen K S, Bolhuis P A, Sixma J J (1979) Human platelet adherence to artery subendothelium is mediated by factor VIII-von Willebrand factor bound to the subendothelium. Nature 279: 636
Shaw E, Giddings J C, Peake I R, Bloom A L (1979) Synthesis of procoagulant factor VIII, factor VIII releated antigen and other coagulation factors by the isolated perfused rat liver. Brit J Haematol 41: 585
Sporn L A, Chavin S I, Marder V J (1985) Biosynthesis of von Willebrand protein by human megakaryocytes. J Clin Invest 76: 1102
Sporn L A, Marder V J, Wagner D D (1986) Inducible secretion of large biologically potent von Willebrand factor multimers. Cell 46: 185
Stel H V, van der Kwast Th H, Veerman E C I (1983) Detection of factor VIII/coagulant antigen in human liver tissue. Nature 303: 530
Takahashi Y., Kalafatis M, Girma J-P, Sewerin K, Andersson L-O, Meyer D (1987) Localization of a factor VIII binding domain on a 34 kilodalton fragment of the N-terminal portion of von Willebrand factor. Blood 70: 1679
Titani K, Kumar S, Takio K, Erisson L H, Wade R D, Ashida K, Walsh K.A., Chopek M W, Sadler E, Fujikawa K (1986) Amino acid sequence of human von Willebrand factor. Biochemistry 25: 3171
Tschopp T B, Weiss H J, Baumgartner H J (1974) Decreased adhesion of platelets to subendothelium in von Willebrand’s disease. J Lab Clin Med 83: 206
Van Dieijen G, Tans G, Rosing J, Hemker H C (1981) The role of phospholipid and factor VIIIa in the activation of bovine factor X. J Biol Chem 256: 3433
Vehar G A, Davie E W (1980) Preparation and properties of bovine factor VIII (antihemophilic factor). Biochemistry 19: 401
Verwey C L, Diergaarde P, Hart M, Pannekoek H (1986) Full-length von Willebrand factor (vWF) cDNA encodes a highly repetitive protein, considerably larger than the mature vWF subunit. EMBO J 5: 1839
Verwey C L, Hart M, Pannekoek H (1987) Expression of variant von Willebrand factor (vWF) cDNA in heterologous cells: requirement of the propolypeptide in vWF multimer assembly. EMBO J 6: 2885
Verwey C L, Hart M, Pannekoek H (1988) Proteolytic cleavage of the precursor of von Willebrand factor (pro-vWF) is not essential for multimer formation. J Biol Chem 263: 7921
Wagner D D, Oluisted J B, Marder V J (1982) Immunolocalization of von Willebrand factor protein in Weibel Palade bodies of human endothelial cells. J Cell Biol 95: 355
Wagner D D, Marder V J (1984) Biosynthesis of von Willebrand protein by human endothelial cells: processing steps and their intracellular localization. J Cell Biol 99: 2123
Wion K L, Kelly D A, Summerfield J A, Tuddenham E G D, Lawn R M (1985) Distribution of factor VIII mRNA and antigen in human liver and other tissues. Nature 317: 726
Wise R J, Pittman D D, Haudin R I, Kaufman R J, Orkin S H (1988) The propolypeptide of von Willebrand factor independently mediates the assembly of von Willebrand multimers. Cell 52: 229
Wood W I, Capon D J, Simonsen C C, Eaton D L, Gitschier J, Keyt B, Seeburg P H, Smith D H, Hollingshead P, Wion K L, Delwart E, Tuddenham E G D, Vehar G A, Lawn R M (1984) Expression of active human factor VIII from recombinant DNA clones. Nature 312: 330
Zelechowska M G, van Mourik J A, Brodniewicz-Proba T (1985) Ultra-structural localization of factor VIII procoagulant antigen in human liver hepatocytes. Nature 317: 729
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
van Mourik, J.A. et al. (1990). Biosynthesis and assembly of the factor VIII-von Willebrand factor complex. In: Harenberg, J., Heene, D.L., Stehle, G., Schettler, G. (eds) New Trends in Haemostasis. Veröffentlichungen aus der Geomedizinischen Forschungsstelle der Heidelberger Akademie der Wissenschaften, vol 1990 / 1990/3. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84318-1_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-84318-1_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-53275-0
Online ISBN: 978-3-642-84318-1
eBook Packages: Springer Book Archive